Cryobiopsy and Forceps Biopsy Go Head-to-Head for Diagnosing Lung Lesions When added to needle aspiration, one method yielded better samples for molecular testing in NSCLC Jan 09, 2024
More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effects Meta-analysis shows increased risk of dementia, Parkinson's, depression Jan 09, 2024
Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC T-cell response linked to 86% reduced risk of relapse, death Jan 09, 2024
Direct Thrombin Inhibitor Shows Benefit for Progressing Stroke Urgent anticoagulation with argatroban shows no bleeding downside in EASE trial Jan 09, 2024
Retinal Tumor Risk Incidentally Detected at 29 Weeks' Gestation Finding poses clinical and ethical dilemma for parents and clinicians Jan 08, 2024
FDA Leaders' Vaccination Warning; Michael Bolton's Brain Tumor; JN.1 Now Dominant Health news and commentary from around the Web gathered by staff Jan 08, 2024
Collaboration Between Local Oncologists and Academia Is Crucial Greater partnerships can optimize cancer care outcomes Jan 06, 2024
Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras News, features, and commentary about cancer-related issues Jan 05, 2024
MeCo Score May Predict Metastatic Progression in Breast Cancer Seeing whether it can predict response to antifibrotic therapies is next step Jan 05, 2024 video
U.S. Rep's Death Medical Negligence? FDA Investigates GLPs; Fingerprint Mammograms Health news and commentary from around the Web gathered by staff Jan 05, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024
Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients Our panel discusses findings from the ZUMA-12 study and the ZUMA-7 study Jan 04, 2024 video
Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma Subcutaneous administration of the anti-CD38 antibody also made for easier dosing Jan 04, 2024
Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma Study results show impressive efficacy, favorable safety profile in the second line Jan 04, 2024 video
Futile Immunotherapy for Cancer Grows More Common Occurs most often at non-academic and low-volume centers Jan 04, 2024
Combination Shows Promise in Metastatic ESR1-Mutant Breast Cancer Durable responses with lasofoxifene plus abemaciclib in post-CDK4/6 inhibitor setting Jan 03, 2024
Paramagnetic Seeds: An Effective Option for Breast Lesion Localization Study finds seeds-SPIO combo compares favorably with guidewire-SPIO for breast-conserving surgery Jan 02, 2024
Lessons From the Chemotherapy Shortages: Invest in Generics We need more sustainable solutions to ensure treatment access Dec 31, 2023
Cancer Patients Face Frightening Delays in Treatment Approvals "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
Gene Therapy for Hemophilia Becomes a Reality Uptake of new options for hemophilia A and B has been a bit slow Dec 29, 2023
Financial Toxicity Among Single Mothers With Metastatic Breast Cancer Diagnosis coupled with financial burden makes for a difficult situation, but help is out there Dec 29, 2023 video
Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer News, features, and commentary about cancer-related issues Dec 28, 2023
Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
Chemo-Free Quadruplet Promising as Initial Treatment in DLBCL Approach could allow for a response-adapted reduction of CHOP Dec 27, 2023 video
Mind of the 'Maestro': Inside the Head of Leonard Bernstein Psychiatrist and concert pianist Richard Kogan, MD, on the great composer's complex inner life Dec 27, 2023
Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCT Randomized study showed extending prophylaxis from 100 to 200 days was effective and safe Dec 27, 2023
Significant Left Nasal Obstruction Finally Diagnosed After 2 Years Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man Dec 26, 2023
Tisa-Cel Yields Durable Responses in R/R Follicular Lymphoma Our panel of experts discuss 3-year findings from the phase II ELARA study Dec 26, 2023 video
SABCS 2023 Highlights Open the Door for More Key Data in 2024 Virginia Kaklamani, MD, discusses this year's sessions of interest and looks ahead to next year Dec 22, 2023 video
Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC News, features, and commentary about cancer-related issues Dec 21, 2023
Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease Dec 21, 2023 video
Homelessness Tied to Worse Cancer Outcomes Among Veterans However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years Bispecific antibody also shows high response rates in frontline setting Dec 20, 2023 video
Positive Results for Odronextamab in Relapsed/Refractory DLBCL But experts aren't sure where it would fit in with currently approved bispecifics Dec 20, 2023 video
'Curable': A Case for Precision of Language Patients need a clear description of their prognosis Dec 19, 2023
Psilocybin May Help Ease Depression in Cancer Patients In small trial, half had early remission of depressive symptoms after psilocybin-assisted therapy Dec 18, 2023
National Database Study Finds Higher Risk for Barrett’s Esophagus in IBD But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
The 'Before and After': An Eye Surgeon's Unexpected Finding There are a few possible diagnoses in patient with headaches, blurred vision, but one stands out Dec 16, 2023
FDA Approves New First-Line Standard of Care in Bladder Cancer Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma Phase II findings on golidocitinib will form the basis of an accelerated approval application Dec 15, 2023